Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 727

1.

Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose-response effects on glucose metabolism in human subjects with metabolic syndrome.

Gilijamse PW, Hartstra AV, Levin E, Wortelboer K, Serlie MJ, Ackermans MT, Herrema H, Nederveen AJ, Imangaliyev S, Aalvink S, Sommer M, Levels H, Stroes ESG, Groen AK, Kemper M, de Vos WM, Nieuwdorp M, Prodan A.

NPJ Biofilms Microbiomes. 2020 Mar 27;6(1):16. doi: 10.1038/s41522-020-0127-0.

2.

Surfactant-dependent critical interfacial tension in silicon carbide membranes for produced water treatment.

Virga E, Bos B, Biesheuvel PM, Nijmeijer A, de Vos WM.

J Colloid Interface Sci. 2020 Mar 13;571:222-231. doi: 10.1016/j.jcis.2020.03.032. [Epub ahead of print]

3.

Back to the Roots: Revisiting the Use of the Fiber-Rich Cichorium intybusL. Taproots.

Puhlmann ML, de Vos WM.

Adv Nutr. 2020 Mar 21. pii: nmaa025. doi: 10.1093/advances/nmaa025. [Epub ahead of print]

PMID:
32199025
4.

Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice.

Depommier C, Van Hul M, Everard A, Delzenne NM, De Vos WM, Cani PD.

Gut Microbes. 2020 Mar 13:1-15. doi: 10.1080/19490976.2020.1737307. [Epub ahead of print]

PMID:
32167023
5.

Stimuli-Responsive Membranes through Sustainable Aqueous Phase Separation.

Willott JD, Nielen WM, de Vos WM.

ACS Appl Polym Mater. 2020 Feb 14;2(2):659-667. doi: 10.1021/acsapm.9b01006. Epub 2019 Dec 3.

6.

Effect of fructans, prebiotics and fibres on the human gut microbiome assessed by 16S rRNA-based approaches: a review.

Swanson KS, de Vos WM, Martens EC, Gilbert JA, Menon RS, Soto-Vaca A, Hautvast J, Meyer PD, Borewicz K, Vaughan EE, Slavin JL.

Benef Microbes. 2020 Mar 27;11(2):101-129. doi: 10.3920/BM2019.0082. Epub 2020 Feb 19.

PMID:
32073295
7.

Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries.

Ghosh TS, Rampelli S, Jeffery IB, Santoro A, Neto M, Capri M, Giampieri E, Jennings A, Candela M, Turroni S, Zoetendal EG, Hermes GDA, Elodie C, Meunier N, Brugere CM, Pujos-Guillot E, Berendsen AM, De Groot LCPGM, Feskins EJM, Kaluza J, Pietruszka B, Bielak MJ, Comte B, Maijo-Ferre M, Nicoletti C, De Vos WM, Fairweather-Tait S, Cassidy A, Brigidi P, Franceschi C, O'Toole PW.

Gut. 2020 Feb 17. pii: gutjnl-2019-319654. doi: 10.1136/gutjnl-2019-319654. [Epub ahead of print]

8.

Pasteurized Akkermansia muciniphila protects from fat mass gain but not from bone loss.

Lawenius L, Scheffler JM, Gustafsson KL, Henning P, Nilsson KH, Colldén H, Islander U, Plovier H, Cani PD, de Vos WM, Ohlsson C, Sjögren K.

Am J Physiol Endocrinol Metab. 2020 Apr 1;318(4):E480-E491. doi: 10.1152/ajpendo.00425.2019. Epub 2020 Jan 21.

9.

Mutual Metabolic Interactions in Co-cultures of the Intestinal Anaerostipes rhamnosivorans With an Acetogen, Methanogen, or Pectin-Degrader Affecting Butyrate Production.

Bui TPN, Schols HA, Jonathan M, Stams AJM, de Vos WM, Plugge CM.

Front Microbiol. 2019 Nov 1;10:2449. doi: 10.3389/fmicb.2019.02449. eCollection 2019.

10.

Overcharging and charge inversion: Finding the correct explanation(s).

de Vos WM, Lindhoud S.

Adv Colloid Interface Sci. 2019 Dec;274:102040. doi: 10.1016/j.cis.2019.102040. Epub 2019 Oct 20. Review.

11.

Akkermansia muciniphila reduces Porphyromonas gingivalis-induced inflammation and periodontal bone destruction.

Huck O, Mulhall H, Rubin G, Kizelnik Z, Iyer R, Perpich JD, Haque N, Cani PD, de Vos WM, Amar S.

J Clin Periodontol. 2020 Feb;47(2):202-212. doi: 10.1111/jcpe.13214. Epub 2019 Dec 2.

PMID:
31674689
12.

Molecular ecology of the yet uncultured bacterial Ct85-cluster in the mammalian gut.

Hynönen U, Zoetendal EG, Virtala AK, Shetty S, Hasan S, Jakava-Viljanen M, de Vos WM, Palva A.

Anaerobe. 2019 Sep 25:102104. doi: 10.1016/j.anaerobe.2019.102104. [Epub ahead of print]

PMID:
31562947
13.

Nafion-Based Low-Hydration Polyelectrolyte Multilayer Membranes for Enhanced Water Purification.

Reurink DM, Te Brinke E, Achterhuis I, Roesink HDW, de Vos WM.

ACS Appl Polym Mater. 2019 Sep 13;1(9):2543-2551. doi: 10.1021/acsapm.9b00689. Epub 2019 Aug 19.

14.

The Gut Microbiota in the First Decade of Life.

Derrien M, Alvarez AS, de Vos WM.

Trends Microbiol. 2019 Dec;27(12):997-1010. doi: 10.1016/j.tim.2019.08.001. Epub 2019 Aug 29. Review.

15.

Surfactant specific ionic strength effects on membrane fouling during produced water treatment.

Dickhout JM, Virga E, Lammertink RGH, de Vos WM.

J Colloid Interface Sci. 2019 Nov 15;556:12-23. doi: 10.1016/j.jcis.2019.07.068. Epub 2019 Aug 3.

16.

Development of omics-based protocols for the microbiological characterization of multi-strain formulations marketed as probiotics: the case of VSL#3.

Mora D, Filardi R, Arioli S, Boeren S, Aalvink S, de Vos WM.

Microb Biotechnol. 2019 Nov;12(6):1371-1386. doi: 10.1111/1751-7915.13476. Epub 2019 Aug 12.

17.

Akkermansia muciniphila Exerts Lipid-Lowering and Immunomodulatory Effects without Affecting Neointima Formation in Hyperlipidemic APOE*3-Leiden.CETP Mice.

Katiraei S, de Vries MR, Costain AH, Thiem K, Hoving LR, van Diepen JA, Smits HH, Bouter KE, Rensen PCN, Quax PHA, Nieuwdorp M, Netea MG, de Vos WM, Cani PD, Belzer C, van Dijk KW, Berbée JFP, van Harmelen V.

Mol Nutr Food Res. 2019 Aug 6:e1900732. doi: 10.1002/mnfr.201900732. [Epub ahead of print]

PMID:
31389129
18.

Universal membrane-labeling combined with expression of Katushka far-red fluorescent protein enables non-invasive dynamic and longitudinal quantitative 3D dual-color fluorescent imaging of multiple bacterial strains in mouse intestine.

Peñate-Medina O, Tower RJ, Peñate-Medina T, Will O, Saris PEJ, Suojanen J, Sorsa T, Huuskonen L, Hiippala K, Satokari R, Glüer CC, de Vos WM, Reunanen J.

BMC Microbiol. 2019 Jul 18;19(1):167. doi: 10.1186/s12866-019-1538-z.

19.

Bicistronic Design-Based Continuous and High-Level Membrane Protein Production in Escherichia coli.

Claassens NJ, Finger-Bou M, Scholten B, Muis F, de Groot JJ, de Gier JW, de Vos WM, van der Oost J.

ACS Synth Biol. 2019 Jul 19;8(7):1685-1690. doi: 10.1021/acssynbio.9b00101. Epub 2019 Jul 2.

20.

Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.

Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, de Barsy M, Loumaye A, Hermans MP, Thissen JP, de Vos WM, Cani PD.

Nat Med. 2019 Jul;25(7):1096-1103. doi: 10.1038/s41591-019-0495-2. Epub 2019 Jul 1.

21.

Cohort profile: Finnish Health and Early Life Microbiota (HELMi) longitudinal birth cohort.

Korpela K, Dikareva E, Hanski E, Kolho KL, de Vos WM, Salonen A.

BMJ Open. 2019 Jun 27;9(6):e028500. doi: 10.1136/bmjopen-2018-028500.

22.

Anaerobic Degradation of N-ε-Carboxymethyllysine, a Major Glycation End-Product, by Human Intestinal Bacteria.

Bui TPN, Troise AD, Fogliano V, de Vos WM.

J Agric Food Chem. 2019 Jun 12;67(23):6594-6602. doi: 10.1021/acs.jafc.9b02208. Epub 2019 May 28.

23.

Enhanced nutrient supply and intestinal microbiota development in very low birth weight infants.

Blakstad EW, Korpela K, Lee S, Nakstad B, Moltu SJ, Strømmen K, Rønnestad AE, Brække K, Iversen PO, de Vos WM, Drevon CA.

Pediatr Res. 2019 Sep;86(3):323-332. doi: 10.1038/s41390-019-0412-x. Epub 2019 May 14.

PMID:
31086354
24.

Gender-Specific Associations Between Saliva Microbiota and Body Size.

Raju SC, Lagström S, Ellonen P, de Vos WM, Eriksson JG, Weiderpass E, Rounge TB.

Front Microbiol. 2019 Apr 10;10:767. doi: 10.3389/fmicb.2019.00767. eCollection 2019.

25.

The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.

Holster S, Lindqvist CM, Repsilber D, Salonen A, de Vos WM, König J, Brummer RJ.

Clin Transl Gastroenterol. 2019 Apr;10(4):e00034. doi: 10.14309/ctg.0000000000000034.

26.

Reconstructing functional networks in the human intestinal tract using synthetic microbiomes.

Shetty SA, Smidt H, de Vos WM.

Curr Opin Biotechnol. 2019 Aug;58:146-154. doi: 10.1016/j.copbio.2019.03.009. Epub 2019 Apr 6. Review.

27.

Akkermansia muciniphila ameliorates the age-related decline in colonic mucus thickness and attenuates immune activation in accelerated aging Ercc1 -/Δ7 mice.

van der Lugt B, van Beek AA, Aalvink S, Meijer B, Sovran B, Vermeij WP, Brandt RMC, de Vos WM, Savelkoul HFJ, Steegenga WT, Belzer C.

Immun Ageing. 2019 Mar 8;16:6. doi: 10.1186/s12979-019-0145-z. eCollection 2019.

28.

Biotechnology of health-promoting bacteria.

Douillard FP, de Vos WM.

Biotechnol Adv. 2019 Nov 1;37(6):107369. doi: 10.1016/j.biotechadv.2019.03.008. Epub 2019 Mar 12. Review.

PMID:
30876799
29.

The Use of Defined Microbial Communities To Model Host-Microbe Interactions in the Human Gut.

Elzinga J, van der Oost J, de Vos WM, Smidt H.

Microbiol Mol Biol Rev. 2019 Mar 13;83(2). pii: e00054-18. doi: 10.1128/MMBR.00054-18. Print 2019 May 15. Review.

30.

Metabolic improvement in obese patients after duodenal-jejunal exclusion is associated with intestinal microbiota composition changes.

de Jonge C, Fuentes S, Zoetendal EG, Bouvy ND, Nelissen R, Buurman WA, Greve JW, de Vos WM, Rensen SS.

Int J Obes (Lond). 2019 Dec;43(12):2509-2517. doi: 10.1038/s41366-019-0336-x. Epub 2019 Feb 14.

PMID:
30765893
31.

Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation.

Bekker V, Zwittink RD, Knetsch CW, Sanders IMJG, Berghuis D, Heidt PJ, Vossen JMJJ, de Vos WM, Belzer C, Bredius RGM, Van't Hof PJ, Lankester AC, Kuijper EJ.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1164-1171. doi: 10.1016/j.bbmt.2019.01.037. Epub 2019 Feb 5.

PMID:
30731251
32.

Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis.

Everard A, Plovier H, Rastelli M, Van Hul M, de Wouters d'Oplinter A, Geurts L, Druart C, Robine S, Delzenne NM, Muccioli GG, de Vos WM, Luquet S, Flamand N, Di Marzo V, Cani PD.

Nat Commun. 2019 Jan 28;10(1):457. doi: 10.1038/s41467-018-08051-7.

33.

The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls.

Jalanka J, Major G, Murray K, Singh G, Nowak A, Kurtz C, Silos-Santiago I, Johnston JM, de Vos WM, Spiller R.

Int J Mol Sci. 2019 Jan 20;20(2). pii: E433. doi: 10.3390/ijms20020433.

34.

Combined Experimental and Theoretical Study of Weak Polyelectrolyte Brushes in Salt Mixtures.

Willott JD, Humphreys BA, Webber GB, Wanless EJ, de Vos WM.

Langmuir. 2019 Feb 19;35(7):2709-2718. doi: 10.1021/acs.langmuir.8b03838. Epub 2019 Feb 7.

35.

Wettability of Amphoteric Surfaces: The Effect of pH and Ionic Strength on Surface Ionization and Wetting.

Virga E, Spruijt E, de Vos WM, Biesheuvel PM.

Langmuir. 2018 Dec 18;34(50):15174-15180. doi: 10.1021/acs.langmuir.8b02875. Epub 2018 Nov 28.

36.

Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans.

Haak BW, Lankelma JM, Hugenholtz F, Belzer C, de Vos WM, Wiersinga WJ.

J Antimicrob Chemother. 2019 Mar 1;74(3):782-786. doi: 10.1093/jac/dky471.

PMID:
30418539
37.

A Bifidobacterial pilus-associated protein promotes colonic epithelial proliferation.

O'Connell Motherway M, Houston A, O'Callaghan G, Reunanen J, O'Brien F, O'Driscoll T, Casey PG, de Vos WM, van Sinderen D, Shanahan F.

Mol Microbiol. 2019 Jan;111(1):287-301. doi: 10.1111/mmi.14155. Epub 2018 Dec 2.

PMID:
30352131
38.

Reclassification of Eubacterium hallii as Anaerobutyricum hallii gen. nov., comb. nov., and description of Anaerobutyricum soehngenii sp. nov., a butyrate and propionate-producing bacterium from infant faeces.

Shetty SA, Zuffa S, Bui TPN, Aalvink S, Smidt H, De Vos WM.

Int J Syst Evol Microbiol. 2018 Dec;68(12):3741-3746. doi: 10.1099/ijsem.0.003041. Epub 2018 Oct 23.

PMID:
30351260
39.

Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants.

Korpela K, Salonen A, Vepsäläinen O, Suomalainen M, Kolmeder C, Varjosalo M, Miettinen S, Kukkonen K, Savilahti E, Kuitunen M, de Vos WM.

Microbiome. 2018 Oct 16;6(1):182. doi: 10.1186/s40168-018-0567-4.

40.

Eubacterium maltosivorans sp. nov., a novel human intestinal acetogenic and butyrogenic bacterium with a versatile metabolism.

Feng Y, Stams AJM, Sánchez-Andrea I, de Vos WM.

Int J Syst Evol Microbiol. 2018 Oct 4. doi: 10.1099/ijsem.0.003028. [Epub ahead of print]

PMID:
30285910
41.

Romboutsia hominis sp. nov., the first human gut-derived representative of the genus Romboutsia, isolated from ileostoma effluent.

Gerritsen J, Umanets A, Staneva I, Hornung B, Ritari J, Paulin L, Rijkers GT, de Vos WM, Smidt H.

Int J Syst Evol Microbiol. 2018 Nov;68(11):3479-3486. doi: 10.1099/ijsem.0.003012. Epub 2018 Sep 18.

PMID:
30226461
42.

Bowel Biofilms: Tipping Points between a Healthy and Compromised Gut?

Tytgat HLP, Nobrega FL, van der Oost J, de Vos WM.

Trends Microbiol. 2019 Jan;27(1):17-25. doi: 10.1016/j.tim.2018.08.009. Epub 2018 Sep 12. Review.

PMID:
30219265
43.

Fucosylated oligosaccharides in mother's milk alleviate the effects of caesarean birth on infant gut microbiota.

Korpela K, Salonen A, Hickman B, Kunz C, Sprenger N, Kukkonen K, Savilahti E, Kuitunen M, de Vos WM.

Sci Rep. 2018 Sep 13;8(1):13757. doi: 10.1038/s41598-018-32037-6.

44.

Enhanced selectivity and performance of heterogeneous cation exchange membranes through addition of sulfonated and protonated Montmorillonite.

Radmanesh F, Rijnaarts T, Moheb A, Sadeghi M, de Vos WM.

J Colloid Interface Sci. 2019 Jan 1;533:658-670. doi: 10.1016/j.jcis.2018.08.100. Epub 2018 Aug 29.

PMID:
30195114
45.

Correction: Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3.

Douillard FP, Mora D, Eijlander RT, Wels M, de Vos WM; PLOS ONE Editors.

PLoS One. 2018 Aug 30;13(8):e0203548. doi: 10.1371/journal.pone.0203548. eCollection 2018.

46.

Early life colonization of the human gut: microbes matter everywhere.

Korpela K, de Vos WM.

Curr Opin Microbiol. 2018 Aug;44:70-78. doi: 10.1016/j.mib.2018.06.003. Epub 2018 Aug 4. Review.

PMID:
30086431
47.

A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects.

Sloan TJ, Jalanka J, Major GAD, Krishnasamy S, Pritchard S, Abdelrazig S, Korpela K, Singh G, Mulvenna C, Hoad CL, Marciani L, Barrett DA, Lomer MCE, de Vos WM, Gowland PA, Spiller RC.

PLoS One. 2018 Jul 26;13(7):e0201410. doi: 10.1371/journal.pone.0201410. eCollection 2018.

48.

Flux, Impact, and Fate of Halogenated Xenobiotic Compounds in the Gut.

Atashgahi S, Shetty SA, Smidt H, de Vos WM.

Front Physiol. 2018 Jul 10;9:888. doi: 10.3389/fphys.2018.00888. eCollection 2018. Review.

49.

Akkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How?

Geerlings SY, Kostopoulos I, de Vos WM, Belzer C.

Microorganisms. 2018 Jul 23;6(3). pii: E75. doi: 10.3390/microorganisms6030075. Review.

50.

Adhesion of emulsified oil droplets to hydrophilic and hydrophobic surfaces - effect of surfactant charge, surfactant concentration and ionic strength.

Dickhout JM, Kleijn JM, Lammertink RGH, de Vos WM.

Soft Matter. 2018 Jul 4;14(26):5452-5460. doi: 10.1039/c8sm00476e.

PMID:
29911238

Supplemental Content

Loading ...
Support Center